Pfizer’s Obesity Pipeline Poised to Challenge Novo Nordisk
Pfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
Compare regional ETFs by cash flow to find the strongest income generator. A quick guide to optimize regional yield strategies.
26,816 articlesPfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
A rumored $111 billion Paramount Warner Bros' deal could fuse studios, streaming, and networks under a private group,...
In 2026, Sharplink makes its first Ethereum purchase, signaling a calculated pivot in treasury strategy. This article...
Investors are tracing a familiar 1990 Gulf War playbook as oil climbs and energy shares outperform, while the broader...
A record M&A surge, pegged at roughly $4 trillion for 2026, is shaping the market. Wall Street is weighing whether a ...
Blend Labs reports a split quarter: Consumer Banking grows while Mortgage slows, as the stock slides about 46% over t...
EasyJet has agreed to a $6.7 billion takeover by a U.S. private equity firm, a deal that could transform routes, fare...
Broadcom and Microsoft posted AI-driven quarters, underscoring two distinct strategies: Broadcom sells AI chips to hy...
Two popular crypto tokens sit at the crossroads of payments and data feeds. This guide breaks down XRP and Chainlink,...
Ford and GM reported solid profits driven by SUVs in 2025, but a cloud of EV costs, tariffs and trade policy question...
A major AI cloud deal sparked a notable move in CoreWeave stock on Wednesday. This article explains what happened, wh...
Jack Schlossberg issues a blunt warning to America’s CEOs: treat culture and AI-driven shifts as core business risks,...